The Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a double blind active extension of the multicentre, randomised, double-blind, parallel-group placebo-controlled study
Abstract
Laquinimod; relapsing-remitting multiple sclerosis; MRI monitoring; double-blind active extension